Taizhen Liang

Trilobatin as an <scp>HIV</scp>‐1 entry inhibitor targeting the <scp>HIV</scp>‐1 Gp41 envelope

Shuwen Yin, Xuanxuan Zhang, Fangyuan Lai et al. · FEBS Letters · 2018 · 30 citations · Full text

Hiv Entry, Biochemistry, Medicine +13

A novel bromodomain inhibitor, CPI-203, serves as an HIV-1 latency-reversing agent by activating positive transcription elongation factor b

Taizhen Liang, Xuanxuan Zhang, Fangyuan Lai et al. · Biochemical Pharmacology · 2019 · 28 citations

Hiv-1 Latency-reversing Agent, Human Retrovirus, Novel Bromodomain Inhibitor +7

The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation

Xuanxuan Zhang, Jian Lin, Taizhen Liang et al. · Acta Pharmacologica Sinica · 2018 · 25 citations · Full text

Viral Reactivation, Medicine, Human Retrovirus +9

N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein

Jiayin Qiu, Taizhen Liang, Junyan Wu et al. · Frontiers in Pharmacology · 2019 · 22 citations · Full text

Glycobiology, Pharmacotherapy, Antiviral Drug +20

UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat

Taizhen Liang, Qiao Zhang, Ziyao Wu et al. · mBio · 2021 · 18 citations · Full text